WO2008149139A3 - Tegaserod fumarate and polymorphic forms - Google Patents
Tegaserod fumarate and polymorphic forms Download PDFInfo
- Publication number
- WO2008149139A3 WO2008149139A3 PCT/GB2008/050395 GB2008050395W WO2008149139A3 WO 2008149139 A3 WO2008149139 A3 WO 2008149139A3 GB 2008050395 W GB2008050395 W GB 2008050395W WO 2008149139 A3 WO2008149139 A3 WO 2008149139A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polymorphic forms
- tegaserod
- fumarate
- relates
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Abstract
The present invention relates to novel polymorphic forms of the fumarate salt of tegaserod, and to processes for the preparation of these novel polymorphic forms. The invention also relates to pharmaceutical compositions comprising these novel polymorphs, and to uses of said compositions for treating patients suffering from gastrointestinal disorders.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1040/MUM/2007 | 2007-06-04 | ||
IN1040MU2007 | 2007-06-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008149139A2 WO2008149139A2 (en) | 2008-12-11 |
WO2008149139A3 true WO2008149139A3 (en) | 2009-07-30 |
Family
ID=39737103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2008/050395 WO2008149139A2 (en) | 2007-06-04 | 2008-05-30 | Tegaserod fumarate and polymorphic forms |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008149139A2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0505322A1 (en) * | 1991-03-22 | 1992-09-23 | Sandoz Ltd. | Aminoguanidines |
WO2005058819A2 (en) * | 2003-12-16 | 2005-06-30 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of tegaserod base and salts thereof |
WO2006116953A1 (en) * | 2005-05-02 | 2006-11-09 | Zentiva, A.S. | A method for the preparation of tegaserod and slected salts thereof |
WO2008077871A1 (en) * | 2006-12-22 | 2008-07-03 | Novartis Ag | Salts of tegaserod |
-
2008
- 2008-05-30 WO PCT/GB2008/050395 patent/WO2008149139A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0505322A1 (en) * | 1991-03-22 | 1992-09-23 | Sandoz Ltd. | Aminoguanidines |
WO2005058819A2 (en) * | 2003-12-16 | 2005-06-30 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of tegaserod base and salts thereof |
WO2006116953A1 (en) * | 2005-05-02 | 2006-11-09 | Zentiva, A.S. | A method for the preparation of tegaserod and slected salts thereof |
WO2008077871A1 (en) * | 2006-12-22 | 2008-07-03 | Novartis Ag | Salts of tegaserod |
Also Published As
Publication number | Publication date |
---|---|
WO2008149139A2 (en) | 2008-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007016538A3 (en) | Preparation and use of biphenyl amino acid derivatives for the treatment of obesity | |
WO2009111700A3 (en) | Oxadiazoanthracene compounds for the treatment of diabetes | |
WO2009064460A3 (en) | Gastrointestinal delivery systems | |
EP2305640A3 (en) | Substituted diphenyl-ethers, -amines, -sulfides and -methanes for the treatment of respiratory diseases | |
WO2009067686A3 (en) | Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof | |
WO2007052023A3 (en) | Novel compounds | |
TW200631583A (en) | Substituted pteridines for the treatment of inflammatory diseases | |
WO2005086656A3 (en) | Heteroarylaminopyrazole derivatives useful for the treatment of diabetes | |
WO2009104021A3 (en) | Novel polymorphs and processes for their preparation | |
WO2006058869A3 (en) | Substituted pteridines for treating inflammatory diseases | |
IL204886B (en) | Pharmaceutical composition for treating gastrointestinal disorders independent of the intake of food | |
WO2010011772A3 (en) | Tri-cyclic pyrazolopyridine kinase inhibitors | |
WO2007138282A3 (en) | Bi-aryl or aryl-heteroaryl substituted indoles | |
WO2008001195A3 (en) | Novel processes for the preparation of dpp iv inhibitors | |
WO2006058867A3 (en) | Substituted pteridines for the treatment of inflammatory diseases | |
WO2006056607A8 (en) | Substituted pteridines for treating inflammatory diseases | |
WO2010055082A3 (en) | New crystal form of sunitinib malate | |
WO2009025785A3 (en) | Cb2 receptor ligands for the treatment of pain | |
WO2011023367A3 (en) | Bisphosphonate-prodrugs | |
WO2009109501A3 (en) | Ocular pharmaceutical compositions | |
WO2005112923A3 (en) | 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes | |
WO2008081268A3 (en) | Pharmaceutical compositions of entacapone | |
WO2006067599A3 (en) | Stable oral benzimidazole compositions and process of preparation thereof | |
WO2010122575A3 (en) | Process for the preparation of pure paliperidone | |
WO2008149154A3 (en) | Tegaserod succinate and polymorphic forms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08750790 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08750790 Country of ref document: EP Kind code of ref document: A2 |